Tci Wealth Advisors, Inc. Rubius Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$4.25 - $10.4 $1,411 - $3,452	-332 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$9.68 - $17.74 $1,558 - $2,856	161 Added 94.15%	332 $3,000
Q3 2021 Oct 29, 2021	BUY	$17.6 - $25.91 $1,443 - $2,124	82 Added 92.13%	171 $3,000
Q2 2021 Aug 02, 2021	BUY	$22.26 - $28.43 $1,981 - $2,530	89 New	89 $2,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.